Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.22EUR
170.34 MEUR
829.51 MEUR
17.95 M
About LABORATORIOS FARMACEUTICOS ROVI S.A.
Sector
CEO
Juan López-Belmonte Encina
Headquarters
Madrid
Website
Employees (FY)
2.11 K
Founded
1946
ISIN
ES0157261019
FIGI
BBG000RL1KS7
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 41L is 82.10 EUR — it has decreased by 4.42% in the past 24 hours. Watch LABORATORIOS FARMACEUT. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange LABORATORIOS FARMACEUT. stocks are traded under the ticker 41L.
41L stock has fallen by 5.52% compared to the previous week, the month change is a 8.17% fall, over the last year LABORATORIOS FARMACEUT. has showed a 100.83% increase.
We've gathered analysts' opinions on LABORATORIOS FARMACEUT. future price: according to them, 41L price has a max estimate of 104.80 EUR and a min estimate of 73.00 EUR. Watch 41L chart and read a more detailed LABORATORIOS FARMACEUT. stock forecast: see what analysts think of LABORATORIOS FARMACEUT. and suggest that you do with its stocks.
41L stock is 4.63% volatile and has beta coefficient of 0.52. Track LABORATORIOS FARMACEUT. stock price on the chart and check out the list of the most volatile stocks — is LABORATORIOS FARMACEUT. there?
Today LABORATORIOS FARMACEUT. has the market capitalization of 4.26 B, it has decreased by 0.68% over the last week.
Yes, you can track LABORATORIOS FARMACEUT. financials in yearly and quarterly reports right on TradingView.
LABORATORIOS FARMACEUT. is going to release the next earnings report on Jul 24, 2024. Keep track of upcoming events with our Earnings Calendar.
41L net income for the last quarter is 51.51 M EUR, while the quarter before that showed 52.18 M EUR of net income which accounts for −1.29% change. Track more LABORATORIOS FARMACEUT. financial stats to get the full picture.
Yes, 41L dividends are paid annually. The last dividend per share was 1.05 EUR. As of today, Dividend Yield (TTM)% is 1.27%. Tracking LABORATORIOS FARMACEUT. dividends might help you take more informed decisions.
As of Jun 24, 2024, the company has 2.11 K employees. See our rating of the largest employees — is LABORATORIOS FARMACEUT. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LABORATORIOS FARMACEUT. EBITDA is 243.80 M EUR, and current EBITDA margin is 29.39%. See more stats in LABORATORIOS FARMACEUT. financial statements.
Like other stocks, 41L shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABORATORIOS FARMACEUT. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LABORATORIOS FARMACEUT. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LABORATORIOS FARMACEUT. stock shows the buy signal. See more of LABORATORIOS FARMACEUT. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.